跳到主要內容

OrbiMed Advisors LLC

SEC CIK
0001055951
最新申報
2026/8/14

2024 年第 4 季持倉

持倉截至 2024/12/31,2025/2/14 申報。只含多頭部位,變化是跟 2024 年第 3 季比股數。

機構總覽
持股檔數
111
較 2024 年第 3 季 +2
總值
$48.2 億
較 2024 年第 3 季 −$6.49 億 (−11.9%)
申報日
2025/2/14
SEC
OrbiMed Advisors LLC 在 2024 年第 4 季的持倉
證券類別股數市值佔組合 %股數變化動作紀錄
EWTXEdgewise Therapeutics, Inc.COM15,021,721$4.01 億8.3%00.0%不變歷史
SVASinovac Biotech LtdSHS2,718,735$3.34 億6.9%00.0%不變歷史
BSXBoston Scientific CorpStock3,160,300$2.82 億5.9%−112,700−3.4%減碼歷史
LLYEli Lilly & CoStock337,600$2.61 億5.4%00.0%不變歷史
ISRGIntuitive Surgical IncCOM NEW401,700$2.10 億4.4%−32,100−7.4%減碼歷史
ELVNEnliven Therapeutics, Inc.COM7,959,538$1.79 億3.7%00.0%不變歷史
NBIXNeurocrine Biosciences IncStock938,120$1.28 億2.7%+635,900+210.4%加碼歷史
SYKStryker CorpStock344,400$1.24 億2.6%00.0%不變歷史
SRPTSarepta Therapeutics, Inc.COM963,400$1.17 億2.4%+8,900+0.9%加碼歷史
ARGXArgenx SESPONSORED ADR189,700$1.17 億2.4%−14,800−7.2%減碼歷史
IRONDisc Medicine, Inc.COM1,785,571$1.13 億2.4%00.0%不變歷史
THCTenet Healthcare CorpCOM NEW792,000$9,997 萬2.1%+10,000+1.3%加碼歷史
IONSIonis Pharmaceuticals IncCOM2,817,347$9,849 萬2.0%+492,900+21.2%加碼歷史
ALNYAlnylam Pharmaceuticals, Inc.COM415,600$9,779 萬2.0%+165,300+66.0%加碼歷史
UPBUpstream Bio, Inc.COM5,693,589$9,360 萬1.9%+5,693,589新進歷史
SPRYARS Pharmaceuticals, Inc.COM8,288,510$8,744 萬1.8%00.0%不變歷史
EWEdwards Lifesciences CorpStock1,145,302$8,479 萬1.8%+1,145,302新進歷史
MRKMerck & Co., Inc.Stock829,900$8,256 萬1.7%−486,100−36.9%減碼歷史
AVBPArriVent BioPharma, Inc.COM3,027,328$8,065 萬1.7%00.0%不變歷史
BIIBBiogen Inc.COM509,100$7,785 萬1.6%−303,900−37.4%減碼歷史
ITGRInteger Holdings CorpCOM575,000$7,620 萬1.6%00.0%不變歷史
CYTKCytokinetics IncCOM NEW1,584,005$7,451 萬1.5%+817,099+106.5%加碼歷史
MBXMBX Biosciences, Inc.COM3,812,215$7,026 萬1.5%00.0%不變歷史
UNHUnitedHealth Group IncStock130,900$6,622 萬1.4%−48,100−26.9%減碼歷史
NTRANatera, Inc.COM413,000$6,538 萬1.4%−274,500−39.9%減碼歷史
VRTXVertex Pharmaceuticals IncStock151,000$6,081 萬1.3%00.0%不變歷史
THRDThird Harmonic Bio, Inc.COM5,779,071$5,947 萬1.2%00.0%不變歷史
CRNXCrinetics Pharmaceuticals, Inc.COM999,000$5,108 萬1.1%−51,055−4.9%減碼歷史
UHSUniversal Health Services IncCL B269,300$4,832 萬1.0%+113,300+72.6%加碼歷史
SIBNSI-BONE, Inc.COM3,442,853$4,827 萬1.0%+137,052+4.1%加碼歷史
SWTXSpringWorks Therapeutics, Inc.COM1,255,031$4,534 萬0.9%−135,600−9.8%減碼歷史
TMOThermo Fisher Scientific Inc.Stock84,400$4,391 萬0.9%00.0%不變歷史
TERNTerns Pharmaceuticals, Inc.COM7,562,971$4,190 萬0.9%00.0%不變歷史
CGONCG Oncology, Inc.COM1,431,114$4,104 萬0.9%+740,000+107.1%加碼歷史
JANXJanux Therapeutics, Inc.COM758,566$4,061 萬0.8%−500,000−39.7%減碼歷史
EXASExact Sciences CorpCOM679,816$3,820 萬0.8%00.0%不變歷史
NPCENeuroPace IncCOM3,406,335$3,812 萬0.8%00.0%不變歷史
XENEXenon Pharmaceuticals Inc.COM947,877$3,716 萬0.8%+36,457+4.0%加碼歷史
CRVSCorvus Pharmaceuticals, Inc.COM6,943,654$3,715 萬0.8%00.0%不變歷史
State Street SPDR S&P Biotech ETF78464A870ETF372,000$3,350 萬0.7%+372,000新進–
CMPXCompass Therapeutics, Inc.COM22,362,850$3,243 萬0.7%00.0%不變歷史
XTNTXtant Medical Holdings, Inc.COM NEW73,114,592$3,239 萬0.7%00.0%不變歷史
Avidity Biosciences, Inc.05370A108COM1,112,886$3,236 萬0.7%+68,081+6.5%加碼–
VERAVera Therapeutics, Inc.CL A742,572$3,140 萬0.7%+66,700+9.9%加碼歷史
DYNDyne Therapeutics, Inc.COM1,227,080$2,891 萬0.6%+518,680+73.2%加碼歷史
CGEMCullinan Therapeutics, Inc.COM1,942,555$2,366 萬0.5%+872,500+81.5%加碼歷史
VIRVir Biotechnology, Inc.COM3,218,617$2,362 萬0.5%−354,383−9.9%減碼歷史
GILDGilead Sciences, Inc.Stock245,600$2,269 萬0.5%+93,900+61.9%加碼歷史
RYTMRhythm Pharmaceuticals, Inc.COM400,000$2,239 萬0.5%−35,900−8.2%減碼歷史
IMTXImmatics N.V.SHS3,087,462$2,195 萬0.5%+1,081,081+53.9%加碼歷史
FOLDAmicus Therapeutics, Inc.COM2,285,400$2,153 萬0.4%+1,715,100+300.7%加碼歷史
SCPHscPharmaceuticals Inc.COM6,059,528$2,145 萬0.4%00.0%不變歷史
RAPTRAPT Therapeutics, Inc.COM13,135,260$2,075 萬0.4%+13,135,260新進歷史
TYRATyra Biosciences, Inc.COM1,470,086$2,043 萬0.4%+701,448+91.3%加碼歷史
MLYSMineralys Therapeutics, Inc.COM1,611,637$1,984 萬0.4%−391,302−19.5%減碼歷史
0000000000Stock12,048,773$1,769 萬0.4%00.0%不變–
GPCRStructure Therapeutics Inc.SPONSORED ADS652,028$1,768 萬0.4%+268,323+69.9%加碼歷史
KROSKeros Therapeutics, Inc.COM1,018,734$1,613 萬0.3%00.0%不變歷史
CCCCC4 Therapeutics, Inc.COM STK4,377,900$1,576 萬0.3%00.0%不變歷史
MEDPMedpace Holdings, Inc.COM44,900$1,492 萬0.3%00.0%不變歷史
VSTMVerastem, Inc.COM NEW2,862,448$1,480 萬0.3%00.0%不變歷史
PRLDPrelude Therapeutics IncCOM10,909,256$1,391 萬0.3%00.0%不變歷史
CRBPCorbus Pharmaceuticals Holdings, Inc.COM NEW1,172,287$1,383 萬0.3%+259,735+28.5%加碼歷史
FBRXForte Biosciences, Inc.COM NEW600,000$1,363 萬0.3%+600,000新進歷史
ITCIIntra-Cellular Therapies, Inc.COM163,000$1,361 萬0.3%+163,000新進歷史
SLRNACELYRIN, Inc.COM4,001,711$1,257 萬0.3%00.0%不變歷史
ABCLAbCellera Biologics Inc.COM4,180,768$1,225 萬0.3%00.0%不變歷史
ADCTADC Therapeutics SASHS5,968,451$1,188 萬0.2%+1,434,650+31.6%加碼歷史
ACETAdicet Bio, Inc.COM11,447,140$1,101 萬0.2%00.0%不變歷史
PMVPPMV Pharmaceuticals, Inc.COM6,475,291$977.8 萬0.2%00.0%不變歷史
NMRANeumora Therapeutics, Inc.COM804,996$853.3 萬0.2%−695,004−46.3%減碼歷史
QTTBQ32 Bio Inc.COM2,252,987$775.0 萬0.2%00.0%不變歷史
GERNGeron CorpCOM2,168,000$767.5 萬0.2%+2,168,000新進歷史
AVTXAvalo Therapeutics, Inc.COM NEW967,000$718.5 萬0.1%00.0%不變歷史
CRDFCardiff Oncology, Inc.COM1,538,462$667.7 萬0.1%+1,538,462新進歷史
SRRKScholar Rock Holding CorpCOM151,800$656.1 萬0.1%−590,500−79.6%減碼歷史
INSMINSMED IncCOM PAR $.0194,559$652.8 萬0.1%+94,559新進歷史
ENGNenGene Therapeutics Inc.COM920,339$612.0 萬0.1%+920,339新進歷史
IMAImageneBio, Inc.COM3,539,358$580.5 萬0.1%00.0%不變歷史
NSPRInspireMD, Inc.COM2,133,405$561.1 萬0.1%00.0%不變歷史
TRAWTraws Pharma, Inc.COM NEW605,531$537.7 萬0.1%00.0%不變歷史
BIOABioAge Labs, Inc.COM921,959$533.8 萬0.1%−501,511−35.2%減碼歷史
XFORX4 Pharmaceuticals, IncCOM7,133,515$523.3 萬0.1%00.0%不變歷史
BCAXBicara Therapeutics Inc.COM298,301$519.6 萬0.1%+26,391+9.7%加碼歷史
MISTMilestone Pharmaceuticals Inc.COM2,000,000$472.0 萬0.1%00.0%不變歷史
RPTXRepare Therapeutics Inc.COM3,322,488$435.2 萬0.1%00.0%不變歷史
PASGPassage BIO, Inc.COM7,404,869$419.9 萬0.1%−2,418,007−24.6%減碼歷史
KRYSKrystal Biotech, Inc.COM23,500$368.2 萬0.1%00.0%不變歷史
ARDTArdent Health, Inc.COM206,000$351.8 萬0.1%00.0%不變歷史
CMMBChemomab Therapeutics Ltd.SPONSORED ADS1,741,273$315.2 萬0.1%00.0%不變歷史
CBLLCeribell, Inc.COM112,500$291.1 萬0.1%+112,500新進歷史
FATEFate Therapeutics IncCOM1,680,580$277.3 萬0.1%00.0%不變歷史
PEPGPepGen Inc.COM653,016$247.5 萬0.1%−144,342−18.1%減碼歷史
TILInstil Bio, Inc.COM NEW116,785$222.9 萬<0.1%+83,085+246.5%加碼歷史
NKTXNkarta, Inc.COM821,400$204.5 萬<0.1%−659,200−44.5%減碼歷史
LYELLyell Immunopharma, Inc.COM3,103,623$198.6 萬<0.1%−2,982,378−49.0%減碼歷史
IMVTImmunovant, Inc.COM78,500$194.4 萬<0.1%+78,500新進歷史
AKROAkero Therapeutics, Inc.COM66,000$183.6 萬<0.1%+66,000新進歷史
TNGXTango Therapeutics, Inc.COM550,000$169.9 萬<0.1%+550,000新進歷史
TSBXTurnstone Biologics Corp.COM3,099,265$154.0 萬<0.1%00.0%不變歷史

選擇權(7 檔)

同一份申報裡的賣權(put)與買權(call)。金額是標的股票的市值,也就是 13F 申報的數字。

OrbiMed Advisors LLC 在 2024 年第 4 季的選擇權部位
證券類別賣權買權
GILDGilead Sciences, Inc.Stock–$1,847 萬
UHSUniversal Health Services IncCL B–$897.1 萬
PFEPfizer IncStock–$663.3 萬
GPCRStructure Therapeutics Inc.SPONSORED ADS–$406.8 萬
SIBNSI-BONE, Inc.COM–$350.5 萬
THCTenet Healthcare CorpCOM NEW–$315.6 萬
CCCCC4 Therapeutics, Inc.COM STK–$54.0 萬

2024 年第 3 季之後清倉(17 檔)

2024 年第 3 季季末還持有、這份申報已經沒有的部位。

OrbiMed Advisors LLC 在 2024 年第 3 季之後清倉的部位
證券類別2024 年第 3 季股數2024 年第 3 季市值2024 年第 3 季佔組合 %紀錄
AMGNAmgen IncStock252,300$8,129 萬1.5%歷史
ELVElevance Health, Inc.Stock106,200$5,522 萬1.0%歷史
REGNRegeneron Pharmaceuticals, Inc.COM45,200$4,752 萬0.9%歷史
EVHEvolent Health, Inc.CL A1,665,115$4,709 萬0.9%歷史
PCVXVaxcyte, Inc.COM387,000$4,422 萬0.8%歷史
SNDXSyndax Pharmaceuticals IncCOM1,925,300$3,706 萬0.7%歷史
APLSApellis Pharmaceuticals, Inc.COM1,270,400$3,664 萬0.7%歷史
ICLRIcon PLCCOM123,900$3,560 萬0.7%歷史
PHATPhathom Pharmaceuticals, Inc.COM1,449,073$2,620 萬0.5%歷史
APGEApogee Therapeutics, Inc.COM379,130$2,227 萬0.4%歷史
LXRXLexicon Pharmaceuticals, Inc.COM NEW11,024,000$1,731 萬0.3%歷史
BNTXBioNTech SESPONSORED ADS103,000$1,223 萬0.2%歷史
ACADAcadia Pharmaceuticals IncCOM764,600$1,176 萬0.2%歷史
OSCROscar Health, Inc.CL A351,618$745.8 萬0.1%歷史
LBPHLongboard Pharmaceuticals, Inc.COM170,000$566.6 萬0.1%歷史
TELATELA Bio, Inc.COM2,161,185$546.8 萬0.1%歷史
VIGLVigil Neuroscience, Inc.COM448,891$152.6 萬<0.1%歷史